Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chills, Fatigue, Headache
Clinical narrative: weakness; pain; chills; fatigue; headache; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 026L20A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included MIRTAZAPINE (REMERON) and ALPRAZOLAM (XANAX) for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Dec-2020, the patient experienced ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 03-Jan-2021, ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Dec-2020, COVID-19: negative negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-022370. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021.    This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 026L20A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included MIRTAZAPINE (REMERON) and ALPRAZOLAM (XANAX) for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Dec-2020, the patient experienced ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 03-Jan-2021, ASTHENIA (weakness), PAIN (pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Dec-2020, COVID-19: negative negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-022370.